TROZX | VIHAX | TROZX / VIHAX | |
Total Expense Ratio | 0.00 | 0.17 | - |
Annual Report Gross Expense Ratio | 0.66 | 0.17 | 388% |
Fund Existence | 5 years | 9 years | - |
Gain YTD | 1.425 | -1.591 | -90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.8B | 9.54B | 124% |
Annual Yield % from dividends | 3.18 | 4.45 | 72% |
Returns for 1 year | 3.48 | -2.64 | -132% |
Returns for 3 years | 28.06 | 2.66 | 1,056% |
Returns for 5 years | 84.58 | 48.57 | 174% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBTH | 22.46 | 0.02 | +0.09% |
iShares iBonds Dec 2027 Term Tr ETF | |||
VLU | 162.34 | -2.71 | -1.64% |
SPDR® S&P 1500 Value Tilt ETF | |||
ECML | 27.05 | -0.67 | -2.41% |
Euclidean Fundamental Value ETF | |||
BUZZ | 19.72 | -0.51 | -2.50% |
VanEck Social Sentiment ETF | |||
IBRN | 18.44 | -0.88 | -4.55% |
iShares Neuroscience and Healthcare ETF |